When taking KRAS mutation as one of the earliest discoveries of genetic alterations in lung cancers (41, 47) and reported as very important for tumor progression (48) into account, there seemed to bear discrepancy at different stages of tumor progression. This evidence concerns the gene KRAS and lung cancer.